VBI (4170.TWO)
TWD 12.25
(-0.81%)
TWD 12.25
(-0.81%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 21.25 Million TWD | -13.22% |
| 2022 | 24.48 Million TWD | -4.74% |
| 2021 | 25.7 Million TWD | 74.95% |
| 2020 | 14.69 Million TWD | -69.93% |
| 2019 | 48.86 Million TWD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 21.32 Million TWD | 67.98% |
| 2024 Q1 | 12.69 Million TWD | -40.25% |
| 2023 Q3 | 12.72 Million TWD | -31.81% |
| 2023 Q2 | 18.66 Million TWD | 89.2% |
| 2023 Q1 | 9.86 Million TWD | -59.72% |
| 2023 FY | 21.25 Million TWD | -13.22% |
| 2023 Q4 | 21.25 Million TWD | 66.99% |
| 2022 Q4 | 24.48 Million TWD | 57.5% |
| 2022 Q3 | 15.54 Million TWD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 96.358% |
| Level Biotechnology Inc. | 273.2 Million TWD | 92.221% |
| Sagittarius Life Science Corp | 137.82 Million TWD | 84.581% |
| NeoCore Technology Co., Ltd. | 197.47 Million TWD | 89.238% |
| TaiMed Biologics Inc. | 1.32 Billion TWD | 98.4% |
| GlycoNex Incorporation | 276.39 Million TWD | 92.311% |
| GeneReach Biotechnology Corp. | 313.7 Million TWD | 93.226% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | 95.871% |
| Visgeneer Inc. | 185.6 Million TWD | 88.55% |
| Mycenax Biotech Inc. | 1.32 Billion TWD | 98.394% |
| Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 97.101% |
| G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | 82.27% |
| Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 99.054% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -221.109% |
| Enimmune corporation | 173.46 Million TWD | 87.749% |
| TaiRx, Inc. | 60.62 Million TWD | 64.947% |
| CHO Pharma, Inc. | 110.83 Million TWD | 80.826% |
| EirGenix Inc. | 1.14 Billion TWD | 98.144% |
| BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | 81.023% |
| Sunny Pharmtech Inc. | 512.43 Million TWD | 95.853% |
| Lin BioScience, Inc. | 167.73 Million TWD | 87.33% |
| BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | 77.324% |
| Feng Chi Biotech Corp. | 63.03 Million TWD | 66.286% |
| Bio Preventive Medicine Corp. | 124.72 Million TWD | 82.962% |
| Lukas Biomedical Inc. | 161.05 Million TWD | 86.805% |
| RBC Bioscience Corporation | 513.08 Million TWD | 95.858% |
| BiOptic Inc. | 170.56 Million TWD | 87.541% |
| BRIM Biotechnology, Inc. | 42.15 Million TWD | 49.592% |
| Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | 8.618% |
| Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | 20.744% |
| Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 97.82% |
| Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | -203.846% |
| SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | -0.118% |
| Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | 94.23% |
| Neith Corporation | 17.43 Million TWD | -21.901% |
| Advagene Biopharma Co., Ltd. | 7.97 Million TWD | -166.57% |
| NaviFUS Corp. | 53.4 Million TWD | 60.205% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | 95.586% |
| Sinew Pharma Inc. | 39.71 Million TWD | 46.49% |
| Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | 63.385% |
| Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | 94.169% |
| Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | 90.667% |
| AP Biosciences Inc | 106.65 Million TWD | 80.074% |
| Medigen Biotechnology Corp. | 3.53 Billion TWD | 99.398% |
| 3D Global Biotech Inc. | 30.68 Million TWD | 30.736% |
| Pharmosa Biopharm Inc. | 195.99 Million TWD | 89.157% |
| Intech Biopharm Corporation | 1.54 Billion TWD | 98.623% |
| Oneness Biotech Co., Ltd. | 866.42 Million TWD | 97.547% |
| Eusol Biotech Co.,Ltd. | 9.27 Million TWD | -129.097% |
| TWi Biotechnology, Inc. | 55.81 Million TWD | 61.925% |
| Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | 90.878% |
| TCI GENE Inc. | 155.54 Million TWD | 86.338% |
| MegaPro Biomedical Co., Ltd | 25.5 Million TWD | 16.689% |
| Senhwa Biosciences, Inc. | 46.17 Million TWD | 53.977% |
| Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | 93.53% |
| NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | 67.249% |
| PharmaEngine, Inc. | 91 Million TWD | 76.649% |
| Savior Lifetec Corporation | 457.95 Million TWD | 95.36% |
| TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | 80.845% |
| OBI Pharma, Inc. | 650.44 Million TWD | 96.733% |
| Meribank Biotech Co., Ltd | 390.81 Million TWD | 94.562% |
| Acepodia, Inc. | 384.47 Million TWD | 94.473% |
| Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | 75.16% |